Co-Processing of Pharmaceutical Solid Waste in Cement Kiln as Alternative Fuel and Raw Material

Abstract

The disposal of pharmaceutical solid waste presents significant environmental and public health challenges due to the presence of hazardous organic compounds, active pharmaceutical ingredients, and complex chemical residues. The present study investigates the co-processing of pharmaceutical solid waste in cement kilns as an alternative fuel and supplementary raw material under industrial operating conditions. The research focuses on evaluating thermal destruction efficiency, energy recovery potential, emission characteristics, clinker quality, and process sustainability associated with cement kiln co-processing systems. Experimental analysis demonstrates that the high-temperature environment and long residence time within cement kilns enable effective decomposition of pharmaceutical contaminants and hazardous organic compounds, resulting in substantial waste volume reduction and safe thermal destruction. Results indicate that optimized feed rate, combustion temperature, waste composition, and kiln operating parameters significantly improve fuel substitution efficiency while maintaining stable clinker production and product quality. The study further reveals that mineral constituents present in pharmaceutical waste contribute to clinker formation, thereby supporting material recovery and reducing the consumption of conventional raw materials. Comparative assessment with conventional incineration and landfill disposal methods confirms the environmental and economic advantages of cement kiln co-processing, including reduced fossil fuel usage, lower greenhouse gas emissions, and minimized secondary waste generation. In addition, emission monitoring indicates that appropriate operational control and pollution mitigation strategies effectively maintain compliance with industrial environmental standards.